Clinical trials
Ocular Diseases clinical trials
Below are recruiting ocular diseases clinical trials, each written for real people, not researchers. We’re tracking 45 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04354545Recruiting
Testing treatments for eye discomfort in glaucoma
This trial studies how to treat eye surface discomfort in people who have glaucoma and are already using multiple eye drops. It may help reduce symptoms like irritation while keeping glaucoma treatment on track.
Fountain Valley, CaliforniaAges Any age - NCT06408701Recruiting
Lab-grown eye cells from people with eye problems
This study uses stem cells from people with eye malformations to grow tiny 3D eye organ-like structures in the lab. The goal is to better understand how eye problems develop, which could lead to new treatments in the future.
Clermont-FerrandAges 6 years+ - NCT06427629Recruiting
Eye cell imaging trial with moxifloxacin drops
This study uses a special camera to look at cells on the surface of your eye. It tests people using moxifloxacin eye drops either before eye surgery or for conditions like dry eye or Sjogren's syndrome.
SeoulAges 19–85 - NCT06780293RecruitingPhase 2
Laser acupuncture for dry eye and Sjogren's dry eye
This study tests if laser acupuncture can help people with dry eye symptoms, including those with Sjogren's syndrome, which causes dryness in the eyes and mouth. It may be a good fit if you have dry eye or Sjogren's and meet the age and eye test requirements.
Taipei, TaiwanAges 20–75 - NCT06919081RecruitingPhase 2
Stem cell eye drops for chronic cornea problems
This study tests whether a special substance from stem cells (called secretome) can help heal chronic surface problems on the eye that haven't gotten better with standard treatments. It's for people with a stubborn scratch or defect on the cornea that has lasted more than 14 days.
Chicago, IllinoisAges 18 years+ - NCT07510087Recruiting
Glaucoma and quality of life study
This study examines how glaucoma affects day-to-day life. It asks people with any type of glaucoma to complete a questionnaire about their quality of life.
Iowa City, IowaAges 18 years+ - NCT07298811RecruitingPhase 1/Phase 2
Healthy eye bacteria for dry eye treatment
This study tests whether putting healthy bacteria from a family member's eye surface onto your eyes can help treat moderate to severe dry eye. You would receive standard dry eye drops plus the experimental transplant.
Nanchang, JiangxiAges 18–70 - NCT06466018Recruiting
Eye disorder biomarkers study for European adults
This study looks for new ways to diagnose and track eye disorders using imaging and genetic tests. It may help find better treatments for conditions linked to blood vessel and nerve problems in the eye.
ParisAges 18 years+ - NCT06984549Recruiting
Dry eye detection via smartphone camera
This study tests if a smartphone can take clear pictures and videos of your eyes to help doctors check for dry eye disease. It may be a simpler way to evaluate dryness from home.
Wenzhou, ZhejiangAges 18 years+ - NCT02821767Recruiting
Study of how different eye problems develop and change over time
This study follows people with eye conditions (including when the diagnosis is unclear) to learn what causes them and how they change. It may help by giving you closer eye evaluations and contributing knowledge that could improve care for future patients.
Bethesda, MarylandAges 1 month–100 years - NCT05414994Recruiting
Study eye bacteria in healthy and eye disease
This study compares the tiny living organisms (“ocular microbiome,” meaning eye-surface bacteria) in different eye conditions. It may help researchers understand how these eye bacteria relate to diseases and why some people develop problems with vision.
Nashville, TennesseeAges 18 years+ - NCT03713268Recruiting
Using a scan to guide eye surgery in real time
This trial tests whether a special eye scan (OCT) can help guide eye surgery during the operation. It may improve how surgeons see and target the exact eye structures they need to treat.
Durham, North CarolinaAges 4 weeks+ - NCT04634383Recruiting
Testing a brain-connected implant to help some blind people see
This early safety study tests an implanted device placed in the brain to help people with very limited sight (no or minimal light). It focuses on whether the implant can be safely used and whether it may support vision-related signals over time.
Chicago, IllinoisAges 19–70 - NCT05214612Recruiting
Predictors of outcomes in myasthenia gravis
This study looks at what helps predict outcomes in people with myasthenia gravis (MG). It may help doctors better forecast how MG will progress and which factors matter most for recovery and long-term health.
AsyutAges 16 years+ - NCT07716397Recruiting
MRI study for thyroid eye disease diagnosis and care
This study uses MRI scans of the eye area to better understand and classify thyroid eye disease (TED). It aims to help doctors predict outcomes and personalize treatment. You may be eligible if you have stable TED or are a healthy volunteer.
Shanghai, Huangpu DistrictAges 18–75 - NCT07605572Recruiting
GLP-1 drugs and dry eye disease in type 2 diabetes
This study tests whether a diabetes and weight-loss medication called GLP-1 receptor agonists affects dry eye disease. Researchers want to see if this medication helps or worsens dry eyes in people with type 2 diabetes and obesity.
AthensAges 18 years+ - NCT07363824Recruiting
Tear iron and dry eye severity study
This study looks at how iron levels in tears relate to the severity of dry eye disease. It aims to find a simple way to measure dry eye severity, which could help doctors better understand and treat the condition.
ShanghaiAges 18–70 - NCT07332988Enrolling by invitation
Light therapy for dry eyes in Graves' disease
This trial tests if low-level light therapy can improve dry eye symptoms in people with Graves' disease whose dry eyes haven't gotten better with standard treatments like artificial tears.
Iași, IaşiAges 18 years+ - NCT06939959RecruitingPhase 4
Insulin eye drops for dry eye disease
This trial tests whether a new type of eye drop made with insulin can help restore the eye's surface and reduce dry eye symptoms. It may be an option for people with moderate to severe dry eye who haven't improved with other treatments.
Peshawar, Khyber PukhtunkhwaAges 18 years+ - NCT06733077Recruiting
Digital services for Parkinson's disease
This study is developing digital services for people with Parkinson's disease and also includes healthy volunteers. It aims to understand movement problems like freezing of gait and festination, and uses a virtual reality system to measure these issues.
ExeterAges 18 years+ - NCT05791864RecruitingPhase 1/Phase 2
Gene therapy for vision loss in CLN2, tested for safety
This early-phase trial studies a gene therapy medicine called TTX-381 to see if it is safe and tolerable in people with CLN2 disease that affects the eyes. The study also looks at how well the treatment fits into existing eye enzyme therapy care.
HamburgAges 1–7
Hear when a new Ocular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ocular diseases?
- Yes. Clin2 currently lists 45 recruiting ocular diseases studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ocular diseases trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ocular diseases trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.